Yasho Industries Ltd Forensic Report - SOIC x StockScans Report

as of Jul 2026

Yasho Industries’ record carries a six-year run of unqualified audit opinions, zero promoter pledges, and fully repaid promoter-family loans. Three things cut against that picture: a promoter family that holds 68% and controls every executive chair while institutional shareholders repeatedly vote against their pay, a mid-tenure auditor resignation followed by a lower-fee replacement, and a cash-conversion record so thin that six years of operations turned only 43 paise of cash for every rupee of EBITDA.

Key findings

  1. Promoters hold 68% and control all executive roles, with pay packages that guarantee payout even in loss years Major - The three executive directors, Vinod Jhaveri, Parag Jhaveri, and Yayesh Jhaveri, are father and sons who co-founded the company and hold 67.91% as of March 31, 2026. At the 39th AGM on September 9, 2025, public institutional shareholders voted 63.15% against the special resolutions to re-appoint and fix their remuneration. The resolutions for FY2021, FY2023, FY2024, and FY2025 all include a clause guaranteeing payment of the approved salary even in the event of loss or inadequacy of profits.
  2. The statutory auditor resigned mid-tenure in June 2024, and the replacement was appointed Major - M/s. V J Shah & Co resigned on 28 June 2024, before completing their second five-year term due to conclude at the 39th AGM in 2025. The company stated the resigning auditor raised no issues, objections or concerns. The board appointed M/s. Gokhale & Sathe on 6 July 2024 at a remuneration to be determined by the Audit Committee and the Board.
  3. Operating cash flow swung from deeply negative to strongly positive in FY26, but six-year cumulative cash generation remains weak Minor - Cumulative CFO of ₹264 crore covered only 0.43x of cumulative EBITDA of ₹617 crore over FY21-FY26. CFO was negative ₹40.85 crore in FY25 and turned positive to ₹151 crore in FY26, the year the Pakhajan greenfield project was commissioned on 9 April 2024. Management stated in the Q4 FY26 call that FY27 capex of ₹125 crore “will be completely funded through internal accruals” without defining the term or reconciling it to cash flow from operations.
  4. Revenue disclosures contain repeated internal contradictions on segment and geographic splits Minor - The FY2025-26 MD&A states category-wise revenue as 89% Consumer Chemicals and 11% Industrial Chemicals in a table, but the explanatory sentence immediately below swaps the labels. The same MD&A reports geography-wise revenue as 62% Domestic and 38% International in a table, but the explanatory sentence states 62% came from international markets with the remaining 32% from domestic sales, which does not sum to 100%. The company received an advance of ₹51.4 crore from a global MNC under a 15-year long-term supply agreement, recorded as a contract liability, with revenue recognition expected to commence only from FY2028.
  5. Two large GST disputes totalling ₹41.90 crore have remained unresolved for over three years, with no provisions made Minor - A GST demand of ₹8.22 crore for denial of pre-import condition and a GST demand of ₹33.68 crore for denial of GST refund on exports have both been pending before various authorities since at least FY2022-23, with the amounts unchanged across four reporting periods. The company made no provision for any of the three contingent liabilities as of March 31, 2026, disclosing them as contingent liabilities rather than recognised obligations.
  6. Audit opinions have been unqualified across all six years, while CARO responses show recurring working-capital statement discrepancies with banks Minor - The statutory auditor issued an unqualified opinion on standalone financial statements for each year from FY2021 through FY2026. The CARO report for each year from FY2022 through FY2026 states that quarterly returns filed with banks for working capital limits were in agreement with books of account except as set out in a specified note. The FY2022 notes disclosed a discrepancy of ₹336.96 lakhs in Q1 FY22 and ₹37.09 lakhs in Q2 FY22 in quarterly statements filed with banks, with the remark “Difference in stock valuation”.
  7. Two minor exchange fines for procedural delays, both paid, with no material regulatory actions against the company Clean - BSE imposed a fine of ₹41,300 for a 7-day delay in filing the half-yearly Related Party Transaction disclosure for the period ended March 31, 2023; the fine was paid on July 28, 2023. BSE and NSE imposed a fine of ₹34,220 for a vacancy in the Company Secretary position; the fine was remitted on October 29, 2024. No significant or material orders have been passed by regulators, courts, or tribunals impacting the company’s going concern status in any year from FY2021 through FY2026.

What to watch

Bottom line: This is a disclosed and audited record with no promoter pledges, no material RPTs, and a clean regulatory history. The risk is concentrated in governance: a promoter family that controls the board and the executive, sets its own pay with guaranteed minimums, and faces persistent institutional dissent, while the auditor who served for years resigned mid-tenure and was replaced at a lower fee. Read the AGM voting results and the GST dispute outcomes with that governance picture in mind, and watch whether the FY27 capex is funded by cash flow or by fresh debt.